Association of Steady-State Concentration, Duration of Action, or Molecular Weight of GLP-1RA With Cardiovascular and Renal Outcomes in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Is the steady-state concentration, duration of action, or molecular weight of GLP-1RA associated with cardiovascular and renal outcomes in type 2 diabetes?
Eur. J. Intern. Med. 2023 Jan 08;[EPub Ahead of Print], S Bai, C Lin, R Jiao, X Cai, S Hu, F Lv, W Yang, X Zhu, L JiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.